Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.16 -0.02 (-0.15%)
Streaming Delayed Price Updated: 10:16 AM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
1 Profitable Stock to Keep an Eye On and 2 We Question
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year ↗
Strong operating results did not stop one fund from walking away entirely, raising questions about how much patience volatile healthcare names really command. 
Via The Motley Fool
News headline image
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 2.2% in the morning session after Citigroup upgraded its rating on the company's shares to Buy from Neutral and raised its price target. The... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks We Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
Via StockStory
Topics Stocks
News headline image
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? ↗
One fund just made a bold move on an eye-care giant—here’s why it may signal a deeper shift in the company’s long-term trajectory. 
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Why Bausch + Lomb (BLCO) Stock Is Up Today
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 4.2% in the morning session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal Weight.". The investment bank... 
Via StockStory
Topics Economy Initial Public Offering
News headline image
3 Small-Cap Stocks with Warning Signs
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
3 Cash-Burning Stocks We Approach with Caution
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
News headline image
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Medical Devices & Supplies - Specialty Stocks Q3 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - specialty stocks fared in Q3,... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Bausch + Lomb’s Q3 Earnings Call
Bausch + Lomb’s third quarter saw a positive market response, as the company posted growth across all major segments and met Wall Street’s revenue expectations. Management highlighted that strong... 
Via StockStory
Topics Earnings
News headline image
BLCO Q3 Deep Dive: Pharmaceuticals and Pipeline Drive Growth, Margin Initiatives Take Shape
Eyecare company Bausch + Lomb (NYSE:BLCO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.1% year on year to $1.28 billion. The company’s outlook for the full year was close to... 
Via StockStory
Topics World Trade
News headline image
Bausch + Lomb Corp (NYSE:BLCO) Q3 2025 Earnings: EPS Beat and Reaffirmed Guidance Drive Shares Higher ↗
Bausch + Lomb (BLCO) Q3 2025 earnings beat EPS estimates by 11.9% and reaffirmed its full-year outlook, driving shares up in pre-market trading. 
Via Chartmill
Topics Earnings
News headline image
Bausch + Lomb (NYSE:BLCO) Reports Q3 In Line With Expectations, Stock Soars
Eyecare company Bausch + Lomb (NYSE:BLCO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.1% year on year to $1.28 billion. The company’s outlook for the full year was close to... 
Via StockStory
News headline image
Bausch + Lomb (BLCO) To Report Earnings Tomorrow: Here Is What To Expect
Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings this Wednesday before the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the morning session after reports revealed an activist investor, Jana Partners, took a stake in competitor Cooper Companies and was... 
Via StockStory
Topics Initial Public Offering World Trade
News headline image
Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report ↗
Jana Partners is urging Cooper to improve capital use and returns, saying its contact-lens and women’s health units lack strategic fit and drag on performance. 
Via Stocktwits
News headline image
3 Stocks Under $50 We Steer Clear Of
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
Topics Economy Supply Chain
News headline image
3 Unpopular Stocks Walking a Fine Line
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics Economy Government World Trade
News headline image
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 2.9% in the afternoon session after the company announced the U.S. launch of its ASANA gas permeable (GP) lenses. This new product line offers... 
Via StockStory
Topics Economy Initial Public Offering Stocks
News headline image
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the afternoon session after comments from Federal Reserve Chair Jerome Powell raised investor hopes for future interest rate cuts. The... 
Via StockStory
Topics Economy Initial Public Offering Stocks
News headline image
Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
News headline image
Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Bausch + Lomb... 
Via StockStory
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 That Underwhelm
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Lawsuit
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.